Day Return
YTD Return
1-Year Return
3-Year Return
5-Year Return
Note: Industry performance is calculated based on the previous closing price of all industry constituents
Largest Companies in This Industry
Name | Last Price | 1Y Target Est. | Market Weight | Market Cap | Day Change % | YTD Return | Avg. Analyst Rating |
---|---|---|---|---|---|---|---|
381.36 | 423.53 | 34.94% | Buy | ||||
234.68 | 275.42 | 17.51% | Buy | ||||
216.98 | 212.34 | 8.23% | Buy | ||||
365.02 | 405.86 | 6.90% | Buy | ||||
36.89 | 45.00 | 4.86% | Hold | ||||
90.64 | 108.36 | 4.65% | Buy | ||||
76.54 | 86.21 | 4.64% | Buy | ||||
146.81 | 146.33 | 2.51% | Buy | ||||
203.01 | 264.50 | 2.47% | Hold | ||||
167.05 | 203.71 | 2.41% | Buy |
Investing in the Medical Instruments & Supplies Industry
Start Investing in Medical Instruments & Supplies Through These Companies
Top Performing Companies
Name | Last Price | 1Y Target Est. | YTD Return |
---|---|---|---|
45.51 | 48.28 | ||
74.22 | 71.13 | ||
216.98 | 212.34 | ||
27.59 | 30.33 | ||
146.81 | 146.33 |
High Growth Companies
Name | Last Price | Growth Estimate | YTD Return |
---|---|---|---|
6.27 | |||
7.52 | |||
12.68 | |||
94.40 | |||
74.22 |
Medical Instruments & Supplies Research
Discover the Latest Analyst and Technical Research for This Industry
Analyst Report: Hologic, Inc.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (60% of total sales, boosted by pandemic), breast health (14% of sales, suppressed by pandemic), surgical (11%), and skeletal health (1%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
RatingPrice TargetAnalyst Report: DENTSPLY SIRONA Inc.
Dentsply Sirona is one of the world’s largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (manufactured dental consumables and lab products) and Sirona Dental Systems (manufactured technologically-advanced dental equipment). The firm’s wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology and equipment through third-party distributors and the remaining portfolio is either sold to labs and offices through the firm’s salesforce or directly to consumers (such as Byte clear aligner).
RatingPrice TargetAnalyst Report: Baxter International Inc.
Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment, including hospital beds, to the portfolio, although about half of Hillrom's revenue comes from more digitally connected offerings like its smart beds and Voalte medical communications app. From its legacy operations, Baxter offers tools to help patients with acute and chronic kidney failure, which it plans to spin off by mid-2024. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents.
RatingPrice TargetAnalyst Report: Baxter International Inc.
Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment, including hospital beds, to the portfolio, although about half of Hillrom's revenue comes from more digitally connected offerings like its smart beds and Voalte medical communications app. From its legacy operations, Baxter offers tools to help patients with acute and chronic kidney failure, which it plans to spin off by mid-2024. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents.
RatingPrice Target